You are here » Home » Companies » Company Overview » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd.

BSE: 500420 Sector: Health care
NSE: TORNTPHARM ISIN Code: INE685A01028
BSE LIVE 15:44 | 08 Dec 1341.25 -1.45
(-0.11%)
OPEN

1350.00

HIGH

1350.00

LOW

1332.90

NSE LIVE 15:51 | 08 Dec 1343.80 0.05
(0.00%)
OPEN

1359.00

HIGH

1359.00

LOW

1332.55

OPEN 1350.00
PREVIOUS CLOSE 1342.70
VOLUME 10918
52-Week high 1767.80
52-Week low 1185.60
P/E 17.93
Mkt Cap.(Rs cr) 22696.63
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1350.00
CLOSE 1342.70
VOLUME 10918
52-Week high 1767.80
52-Week low 1185.60
P/E 17.93
Mkt Cap.(Rs cr) 22696.63
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd is one of the leading pharmaceutical companies having presence in Indian and global markets. The company is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. The company has their presence in 50 countries ...> More

Torrent Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   22,697
EPS - TTM () [*C] 74.81
P/E Ratio (X) [*C] 17.93
Face Value ()   5
Latest Dividend (%)   300.00
Latest Dividend Date 16 Mar 2016
Dividend Yield (%) 2.61
Book Value / Share () [*C] 237.71
P/B Ratio () [*C] 5.64
[*C] Consolidated     [*S] Standalone

Torrent Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 1429 1693 -15.59
Other Income 43 71 -39.44
Total Income 1472 1764 -16.55
Total Expenses 1099 976 12.6
Operating Profit 373 788 -52.66
Net Profit 207 509 -59.33
Equity Capital 85 85 -
> More on Torrent Pharmaceuticals Ltd Financials Results

Torrent Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Piramal Enterp. 1732.25 1.96 29889.97
Glenmark Pharma. 890.75 2.13 25136.96
Glaxosmit Pharma 2732.60 0.34 23145.12
Torrent Pharma. 1341.25 -0.11 22696.63
Alkem Lab 1678.75 0.20 20069.46
Biocon 922.50 0.64 18450.00
Ajanta Pharma 1905.25 1.55 16766.20
> More on Torrent Pharmaceuticals Ltd Peer Group

Torrent Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 71.25
Banks/FIs 0.12
FIIs 11.04
Insurance 0.00
Mutual Funds 7.00
Indian Public 8.24
Custodians 0.00
Other 2.36
> More on Torrent Pharmaceuticals Ltd Share Holding Pattern

Torrent Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
02/11 Motilal Oswal Buy 1542 PDF IconDetails
29/01 Motilal Oswal Buy 1138 PDF IconDetails
> More on Torrent Pharmaceuticals Ltd Research Reports

Torrent Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -3.44% -3.43% 0.51% 0.66%
1 Month 2.05% 2.22% -3.25% -3.47%
3 Month -20.28% -20.11% -8.09% -7.88%
6 Month -3.84% -3.85% -1.21% -0.32%
1 Year -8.08% -7.93% 5.47% 7.08%
3 Year 172.94% 172.00% 27.14% 31.74%

Torrent Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 1332.90
1350.00
Week Low/High 1302.25
1420.00
Month Low/High 1185.60
1465.00
YEAR Low/High 1185.60
1768.00
All TIME Low/High 8.13
1768.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard